Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions

  1. Lookup NU author(s)
  2. Dr John Byrne
  3. Julie Freeman-Edward
  4. Gavin Cuthbert
  5. Dr Nicholas Bown
Author(s)Huntly BJP, Guilhot F, Reid AG, Vassiliou G, Hennig E, Franke C, Byrne J, Brizard A, Niederwieser D, Freeman-Edward J, Cuthbert G, Bown N, Clark RE, Nacheva EP, Green AR, Deininger MWN
Publication type Article
JournalBlood
Year2003
Volume102
Issue6
Pages2205-2212
ISSN (print)0006-4971
ISSN (electronic)1528-0020
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAmerican Society of Hematology
URLhttp://dx.doi.org/10.1182/blood-2002-09-2763
DOI10.1182/blood-2002-09-2763
Actions    Link to this publication